Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gorman

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Arts & Health|September 11, 2023
Crafting representations of rare disease: collage as qualitative inquiryRichard Gorman, Bobbie Farsides, Maria Bonner
Therapeutic Advances in Rare Disease|May 14, 2023
Improving patient informed consent for haemophilia gene therapy: the case for changeLaurence Woollard, Richard Gorman, Dakota J Rosenfelt
Laboratory Animals|February 18, 2021
The social aspects of genome editing: publics as stakeholders, populations and participants in animal researchGail Davies, Richard Gorman, Renelle McGlacken, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2026
The Value of Public Inquiries, Ethical Accountability, and Patient Voices: Reflections on the Infected Blood InquiryRichard Gorman, Clive Smith, Bobbie Farsides, et al.
Journal of Aging Studies|November 19, 2021
Multi-species dementia studies: Contours, contributions and controversiesNicholas Jenkins, Richard Gorman, Cristina Douglas, et al.
Clinical Pediatrics|June 5, 2010
Differences in pediatric drug information sources used by general versus subspecialist pediatriciansEsther Y Yoon, Sarah J Clark, Richard Gorman, et al.
Emergency Medicine Journal : EMJ|June 27, 2025
Management of haemophilia and heritable bleeding disorders in the EDElizabeth Helen Horn, Kate Forsyth, Richard Gooding, et al.
Clinical Lung Cancer|January 18, 2016
Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung CancerJared M Weiss, Liza C Villaruz, Jonathon O'Brien, et al.
Research and Practice in Thrombosis and Haemostasis|October 6, 2025
Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors' OrganisationCaroline Wall, Hua Xiang, Ben Palmer, et al.
Medical Humanities|February 21, 2020
Animal research nexus: a new approach to the connections between science, health and animal welfareGail Davies, Richard Gorman, Beth Greenhough, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Arts & Health|September 11, 2023
Crafting representations of rare disease: collage as qualitative inquiryRichard Gorman, Bobbie Farsides, Maria Bonner
Therapeutic Advances in Rare Disease|May 14, 2023
Improving patient informed consent for haemophilia gene therapy: the case for changeLaurence Woollard, Richard Gorman, Dakota J Rosenfelt
Laboratory Animals|February 18, 2021
The social aspects of genome editing: publics as stakeholders, populations and participants in animal researchGail Davies, Richard Gorman, Renelle McGlacken, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2026
The Value of Public Inquiries, Ethical Accountability, and Patient Voices: Reflections on the Infected Blood InquiryRichard Gorman, Clive Smith, Bobbie Farsides, et al.
Journal of Aging Studies|November 19, 2021
Multi-species dementia studies: Contours, contributions and controversiesNicholas Jenkins, Richard Gorman, Cristina Douglas, et al.
Clinical Pediatrics|June 5, 2010
Differences in pediatric drug information sources used by general versus subspecialist pediatriciansEsther Y Yoon, Sarah J Clark, Richard Gorman, et al.
Emergency Medicine Journal : EMJ|June 27, 2025
Management of haemophilia and heritable bleeding disorders in the EDElizabeth Helen Horn, Kate Forsyth, Richard Gooding, et al.
Clinical Lung Cancer|January 18, 2016
Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung CancerJared M Weiss, Liza C Villaruz, Jonathon O'Brien, et al.
Research and Practice in Thrombosis and Haemostasis|October 6, 2025
Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors' OrganisationCaroline Wall, Hua Xiang, Ben Palmer, et al.
Medical Humanities|February 21, 2020
Animal research nexus: a new approach to the connections between science, health and animal welfareGail Davies, Richard Gorman, Beth Greenhough, et al.
Pageof 3